Growth Hormone AxisIn StockGrowth Hormone Axis
GHRP-2
Also known as: Pralmorelin, KP-102
Synthetic hexapeptide GHS-R1a agonist used in pituitary-axis and ghrelin-pathway research.
GHRP-2 (pralmorelin) is a synthetic hexapeptide and growth-hormone-releasing peptide, classified pharmacologically as a GHS-R1a agonist.
It was one of the earlier second-generation GHRPs developed in the 1990s and remains a standard reference compound in the growth-hormone-secretagogue literature.Research on GHRP-2 spans pituitary physiology, ghrelin-receptor signal transduction, and comparative pharmacology with GHRP-6, Hexarelin, and Ipamorelin.
Published studies have examined its effects on GH pulse dynamics, appetite-signaling research, and cardiovascular models.GHRP-2 is widely available across mid-tier research suppliers and is frequently paired with GHRH analogs (such as CJC-1295 no DAC) in combination research.
Research applications
- GHS-R1a signal-transduction research
- Comparative GHRP pharmacology
- GH pulse-amplitude and frequency studies
- Appetite-signaling and ghrelin-pathway biology
- Combination research with GHRH analogs
Technical profile
- Net content
- 10 mg
- Molecular formula
- C45H55N9O6
- Molecular weight
- 817.92 g/mol
- CAS
- 158861-67-7
- Sequence
- D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
For research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease. Catalog availability restricted to verified licensed practitioners.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that stimulates GH secretion via the ghrelin receptor. It is one of the most potent GHRPs and also increases appetite and gastric motility in research models.
